157 related articles for article (PubMed ID: 19354002)
1. Rosuvastatin-induced rhabdomyolysis probably via CYP2C9 saturation.
Gallelli L; Ferraro M; Spagnuolo V; Rende P; Mauro GF; De Sarro G
Drug Metabol Drug Interact; 2009; 24(1):83-7. PubMed ID: 19354002
[TBL] [Abstract][Full Text] [Related]
2. Rosuvastatin induced rhabdomyolysis in a low risk patient: a case report and review of the literature.
Khan FY; Ibrahim W
Curr Clin Pharmacol; 2009 Jan; 4(1):1-3. PubMed ID: 19149497
[TBL] [Abstract][Full Text] [Related]
3. Rhabdomyolysis with cardiac involvement and acute renal failure in a patient taking rosuvastatin and fenofibrate.
Ireland JH; Eggert CH; Arendt CJ; Williams AW
Ann Intern Med; 2005 Jun; 142(11):949-50. PubMed ID: 15941707
[No Abstract] [Full Text] [Related]
4. McArdle disease with rhabdomyolysis induced by rosuvastatin: case report.
Lorenzoni PJ; Silvado CE; Scola RH; Luvizotto M; Werneck LC
Arq Neuropsiquiatr; 2007 Sep; 65(3B):834-7. PubMed ID: 17952291
[TBL] [Abstract][Full Text] [Related]
5. Rhabdomyolysis induced by rosuvastatin and sildenafil.
Pennisi G; Vacante M; Russo C; Malaguarnera M
South Med J; 2010 Oct; 103(10):1052-4. PubMed ID: 20818298
[TBL] [Abstract][Full Text] [Related]
6. [Possible rosuvastatin-induced fatal rhabdomyolysis].
Pérez Díaz I; Sánchez Argaiz M; Sánchez Gómez E
Farm Hosp; 2011; 35(6):340-1. PubMed ID: 21530345
[No Abstract] [Full Text] [Related]
7. Rosuvastatin and the statin wars--the way to peace.
Meyboom RH; Edwards IR
Lancet; 2004 Dec 4-10; 364(9450):1997-9. PubMed ID: 15582043
[No Abstract] [Full Text] [Related]
8. Rosuvastatin (Crestor) and rhabdomyolysis.
Wooltorton E
CMAJ; 2004 Jul; 171(2):129. PubMed ID: 15262879
[No Abstract] [Full Text] [Related]
9. Elevated serum transaminase levels resulting from concomitant use of rosuvastatin and amiodarone.
Merz T; Fuller SH
Am J Health Syst Pharm; 2007 Sep; 64(17):1818-21. PubMed ID: 17724362
[TBL] [Abstract][Full Text] [Related]
10. Rosuvastatin-warfarin drug interaction.
Barry M
Lancet; 2004 Jan; 363(9405):328. PubMed ID: 14751711
[No Abstract] [Full Text] [Related]
11. The safety of rosuvastatin in comparison with other statins in over 100,000 statin users in UK primary care.
García-Rodríguez LA; Massó-González EL; Wallander MA; Johansson S
Pharmacoepidemiol Drug Saf; 2008 Oct; 17(10):943-52. PubMed ID: 18425988
[TBL] [Abstract][Full Text] [Related]
12. By the way, doctor. I am 80 and am taking a 40-milligram Crestor pill every day. Recently I saw a Crestor ad that said blood tests should be done to monitor for possible side effects of liver or muscle injury. Can you tell me something about those tests?
Komaroff AL
Harv Health Lett; 2007 Mar; 32(5):8. PubMed ID: 17390496
[No Abstract] [Full Text] [Related]
13. Predictors and outcomes of increases in creatine phosphokinase concentrations or rhabdomyolysis risk during statin treatment.
van Staa TP; Carr DF; O'Meara H; McCann G; Pirmohamed M
Br J Clin Pharmacol; 2014 Sep; 78(3):649-59. PubMed ID: 24602118
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of rosuvastatin.
Olsson GO
Lancet; 2004 Jul 10-16; 364(9429):135. PubMed ID: 15246717
[No Abstract] [Full Text] [Related]
15. Dangers of rosuvastatin identified before and after FDA approval.
Wolfe SM
Lancet; 2004 Jun; 363(9427):2189-90. PubMed ID: 15220045
[No Abstract] [Full Text] [Related]
16. Rhabdomyolysis and acute renal failure following hard physical activity in a patient treated with rosuvastatin.
Martínez-López D; Enríquez R; Sirvent AE; Redondo-Pachón MD; Millán I; Amorós F
Nefrologia; 2012; 32(1):127-8. PubMed ID: 22294017
[No Abstract] [Full Text] [Related]
17. Rosuvastatin safety: lessons from the FDA review and post-approval surveillance.
Davidson MH
Expert Opin Drug Saf; 2004 Nov; 3(6):547-57. PubMed ID: 15500414
[TBL] [Abstract][Full Text] [Related]
18. Pressure group urges rosuvastatin recall.
Ault A
Lancet; 2004 Mar; 363(9412):871. PubMed ID: 15032242
[No Abstract] [Full Text] [Related]
19. Safety profile of rosuvastatin: results of a prescription-event monitoring study of 11,680 patients.
Kasliwal R; Wilton LV; Cornelius V; Aurich-Barrera B; Shakir SA
Drug Saf; 2007; 30(2):157-70. PubMed ID: 17253880
[TBL] [Abstract][Full Text] [Related]
20. The safety of rosuvastatin in comparison with other statins in over 25,000 statin users in the Saskatchewan Health Databases.
García-Rodríguez LA; González-Pérez A; Stang MR; Wallander MA; Johansson S
Pharmacoepidemiol Drug Saf; 2008 Oct; 17(10):953-61. PubMed ID: 18425987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
